Clinical Trial Update: Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pegylated interferon alone or in combination with ezetimibe for chronic hepatitis D; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Aga Khan University | Conditions: Hepatitis D, Chronic | Phase 2 | Status: UNKNOWN